Year-end report 2007

Key events in the fourth quarter
• New portfolio company Likvor AB
• ONCOlog Medical enters into partnership with C-RAD
• Ortoviva announces start of clinical trials 2008
• Yvonne Axelsson new CFO

Key events after the period end
• Agneta Edberg new Chief Operating Officer (COO) and Jonas Graff-Lonnevig new VP Financial Transactions, responsible for exits

Financial information for 2007
• Results from investment activities were SEK -10.4 million (-2.5), of which SEK -10.4 million (0.0) in the fourth quarter as a result of the write down of LinkMed’s holding in SACS Medical
• Other income amounted to SEK 5.0 million (4.0), of which SEK 1.3 million (1.3) in the fourth quarter
• Net income/loss after tax was SEK -19.2 million (-14.5), of which SEK -13.3 million (-4.0) in the fourth quarter
• Earnings per share was SEK -2.20 (-2.58)
• Shareholders’ equity was SEK 278.5 million (296.2)
• Equity per share was SEK 31.93 (33.96)
• Equity/assets ratio was 98 (97) percent
• Liquid funds amounted to SEK 125.2 million (202.7)

Comments on 2007 from LinkMed CEO, Ingemar Lagerlöf:
“I am very pleased with the development of most of our portfolio companies last year and would like to point out that several of them have reached important milestones. A number of these companies have reached such a level of maturity that it is time for us to prepare for our exit as an owner. We have therefore strengthened our organization and I estimate that we will have carried out a couple of exits before 2010.”


For additional information, please contact:
Ingemar Lagerlöf, CEO, cell: +46 (0)70-873 2733 or e-mail ingemar.lagerlof@linkmed.se
Okee Williams, Portfolio Manager, cell: +46 (0) 70- 600 5364 or e-mail okee.williams@linkmed.se